Pages that link to "Q47794928"
Jump to navigation
Jump to search
The following pages link to Protective effects of CGS 30440, a combined angiotensin-converting enzyme inhibitor and neutral endopeptidase inhibitor, in a model of chronic renal failure (Q47794928):
Displaying 9 items.
- Vasopeptidase inhibitors (Q34436579) (← links)
- Novel approaches to the treatment of progressive renal disease (Q34443235) (← links)
- Evidence for cardioprotective, renoprotective, and vasculoprotective effects of vasopeptidase inhibitors in disease (Q34444824) (← links)
- Emerging drugs for renal failure (Q35602657) (← links)
- Inhibitory Effect of Phenolic Extract from Garlic on Angiotensin-1 Converting Enzyme and Cisplatin induced Lipid Peroxidation - In Vitro (Q37002302) (← links)
- A double-blind, placebo-controlled study to assess tolerability, pharmacokinetics and preliminary pharmacodynamics of single escalating doses of Z13752A, a novel dual inhibitor of the metalloproteases ACE and NEP, in healthy volunteers (Q41612183) (← links)
- Natriuretic and renoprotective effect of chronic oral neutral endopeptidase inhibition in acute renal failure (Q43108532) (← links)
- Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathy (Q44499796) (← links)
- Polyphenolic compositions and in vitro angiotensin-I-converting enzyme inhibitory properties of common green leafy vegetables: A comparative study (Q91831106) (← links)